Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-04-07
1994-10-25
Chang, Celia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
500455, 500456, A61K 31395, C07D49816
Patent
active
053589440
ABSTRACT:
A compound of the structure ##STR1## wherein R.sup.1, R.sup.2, and R.sup.3 are each, independently, hydrogen or ##STR2## with the proviso that R.sup.1, R.sup.2, and R.sup.3 are not all hydrogen; R.sup.4 is --(CH.sub.2).sub.m X(CH.sub.2).sub.n CO.sub.2 R.sup.5 or ##STR3## R.sup.5 and R.sup.6 are each, independently, alkyl, aralkyl, or phenyl which is optionally mono-, di-, or tri-substituted with a substituent selected from alkyl, alkoxy, hydroxy, cyano, halo, nitro, carbalkoxy, trifluoromethyl, amino, or a carboxylic acid;
REFERENCES:
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 3993749 (1976-11-01), Sehgal et al.
patent: 4316885 (1982-02-01), Rakhit
patent: 4401653 (1983-08-01), Eng
patent: 4650803 (1987-03-01), Stella et al.
patent: 4885171 (1989-12-01), Surendra et al.
patent: 5078990 (1992-01-01), Warner et al.
patent: 5080899 (1992-01-01), Sturm et al.
patent: 5091389 (1992-02-01), Ondeyka et al.
patent: 5100883 (1992-03-01), Schiehser
patent: 5100899 (1992-03-01), Calne
Venzina, C., J. Antibiot. 28:721 (1975).
Sehgal, S. N., J. Antibiot. 28:727 (1975).
Baker, H. J., Antibiot. 31:539 (1978).
Martel, R. R., Can. J. Physiol. Pharmacol. 55:48 (1977).
Staruch, M. J., FASEB 3:3411 (1989).
Dumont, F. J., FASEB 3:5256 (1989).
Calne, R. Y., Lancet 1183 (1978).
C. V. Moseby Co., Immunology, 12.8 (1989).
Morris, R E., Med. Sci. Res. 17:877 (1989).
Rosen et al "Dictionary of Immunology" Elsevier, p. 18, 88 (1990).
Hayger et al "Introduction to Immunology" Jones and Bailett, p. 161 (1985).
American Home Products Corporation
Chang Celia
Milowsky Arnold S.
LandOfFree
Rapamycin esters for treating transplantation rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapamycin esters for treating transplantation rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapamycin esters for treating transplantation rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135518